Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United States Antimony (UAMY) Current Deferred Revenue (2016 - 2020)

United States Antimony (UAMY) has disclosed Current Deferred Revenue for 8 consecutive years, with $32400.0 as the latest value for Q3 2020.

  • Quarterly Current Deferred Revenue changed 0.0% to $32400.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $32400.0 through Sep 2020, changed 0.0% year-over-year, with the annual reading at $32400.0 for FY2019, 0.0% changed from the prior year.
  • Current Deferred Revenue hit $32400.0 in Q3 2020 for United States Antimony, roughly flat from $32400.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $78730.0 in Q2 2016 to a low of $32400.0 in Q2 2018.
  • Historically, Current Deferred Revenue has averaged $50921.9 across 5 years, with a median of $32400.0 in 2018.
  • Biggest five-year swings in Current Deferred Revenue: changed 0.0% in 2016 and later crashed 58.85% in 2018.
  • Year by year, Current Deferred Revenue stood at $78730.0 in 2016, then fell by 23.73% to $60049.0 in 2017, then crashed by 46.04% to $32400.0 in 2018, then changed by 0.0% to $32400.0 in 2019, then changed by 0.0% to $32400.0 in 2020.
  • Business Quant data shows Current Deferred Revenue for UAMY at $32400.0 in Q3 2020, $32400.0 in Q2 2020, and $32400.0 in Q1 2020.